Implantable cardioverter-defibrillators in congenital heart disease

Area of Science:

• Cardiology
• Medical Devices

Background:

• Implantable cardioverter-defibrillators (ICDs) are vital for preventing sudden cardiac death (SCD) in patients with congenital heart disease (CHD).
• Evaluating the risks and benefits of ICDs in the diverse CHD population presents unique challenges.
• A personalized approach is essential for effective ICD implantation and management in CHD patients.

Purpose of the Study:

• To review primary and secondary indications for ICD implantation in CHD patients.
• To discuss implantation techniques and long-term follow-up strategies for ICDs in this population.
• To highlight recent findings on system longevity, lead extraction, inappropriate shocks, and quality of life.

Main Methods:

• This review synthesizes information from recent publications and clinical guidelines.
• It focuses on risk stratification and patient-specific factors for tailored ICD strategies.
• The review examines challenges in managing ICDs in the heterogeneous CHD population.

Main Results:

• ICDs play a significant role in reducing SCD in CHD patients.
• Adverse effects, including system longevity issues and lead complications, require careful evaluation.
• Inappropriate shocks and impact on quality of life are critical considerations for long-term management.

Conclusions:

• A tailored approach considering individual risk factors and patient-specific characteristics is necessary for ICD selection in CHD.
• Long-term follow-up must address system longevity, lead issues, shock burden, and quality of life.
• Careful consideration of all factors is paramount before committing to ICD therapy in CHD patients.